LD-2 disclosure · 1st Quarter - Report
SANOTIZE RESEARCH & DEVELOPMENT CORPORATION
via DAVID GENCARELLI
Client
- Description
- Development of anti-microbial medicines from nitric oxide
- Location
- British Columbia · Canada
Registrant
- Firm
- DAVID GENCARELLI
- Description
- Legislative and regulatory consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Outreach to Senate HELP committee and House energy & Commerce seeking support for grant research grant efforts with HHS agencies. Outreach to BARDA, DoD, VHA and Assistant Secretary of Health for Preparedness and Emergency Response to discuss approval and future utilization of clients respiratory disease treatment products.
Lobbyistsmr DAVID F GENCARELLI
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD) · Defense Advanced Research Projects Agency (DARPA) · Centers For Disease Control & Prevention (CDC) · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
Supporting Submission of request for budget report language supporting US funding for support of human trials of clients product in the United States through contacts with Members of House and Senate
Lobbyistsmr DAVID F GENCARELLI
TargetedDefense Threat Reduction Agency (DTRA)
Medical/Disease Research/Clinical Labs
Outreach to Department of Defense Military Research Military Command (MRDC),HHS and National INstitute of Allergy & Infectious Disease (NIAID) and Biological Research & Development Authority (BARDA) and JPEU-CBRN
mr DAVID F GENCARELLI